Seeking Alpha

AKAO
  Achaogen - NASDAQ

8/22/2014, 10:52 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
AKAO vs. ETF Alternatives
Company Description
Achaogen Inc is a clinical-stage biopharmaceutical company. The Company develops, discovers and commercializes antibacterials to treat multi-drug resistant gram-negative infections.
Sector: Healthcare
Industry: Biotechnology
Country: United States